Discovery of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors via Pharmacophore-linked Fragment Virtual Screening Approach.
Discovery of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors via Pharmacophore-linked Fragment Virtual Screening Approach.
复制标题
DOI:
10.1021/acs.jafc.6b00325
复制
发表时间:
2016-06
影响因子:
6.1
通讯作者:
Li Xiong;Xiao-Lei Zhu;Hua Gao;Yunshuang Fu;Sheng-quan Hu;Lina Jiang;Wenchao Yang;Guangfu Yang
中科院分区:
文献类型:
--
作者:
Li Xiong;Xiao-Lei Zhu;Hua Gao;Yunshuang Fu;Sheng-quan Hu;Lina Jiang;Wenchao Yang;Guangfu Yang
Succinate-ubiquinone oxidoreductase (SQR) is an attractive target for fungicide discovery. Herein, we report the discovery of novel SQR inhibitors using a pharmacophore-linked fragment virtual screening approach, a new drug design method developed in our laboratory. Among newly designed compounds, compound 9s was identified as the most potent inhibitor with a Ki value of 34 nM against porcine SQR, displaying approximately 10-fold higher potency than that of the commercial control penthiopyrad. Further inhibitory kinetics studies revealed that compound 9s is a noncompetitive inhibitor with respect to the substrate cytochrome c and DCIP. Interestingly, compounds 8a, 9h, 9j, and 9k exhibited good in vivo preventive effects against Rhizoctonia solani. The results obtained from molecular modeling showed that the orientation of the R(2) group had a significant effect on binding with the protein.